FDA

News

scientifically visualization of a coronavirus spike protein

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

GlaxoSmithKline's COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered vaccine candidate as well as an FDA emergency approval for antibody sot

News

FDA fires broadside at CytoDyn over COVID-19 antibody data

In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19.

News

FDA authorises Pfizer/BioNTech vaccine for adolescents

The FDA has authorised Pfizer/BioNTech’s vaccine for 12- to 15 year-olds under emergency rules.

News

MDMA on track for 2023 approval as PTSD therapy, says develo...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the org

News

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.

News

AstraZeneca's Farxiga claims first SGLT2 kidney disease OK f...

AstraZeneca is already seeing sales rocket for its SGLT2 inhibitor Farxiga in heart failure, and is expected to gather even more momentum after claiming FDA approval in chronic kidney disea

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

FDA fires broadside at CytoDyn over COVID-19 antibody data

FDA authorises Pfizer/BioNTech vaccine for adolescents

MDMA on track for 2023 approval as PTSD therapy, says develo...

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

AstraZeneca's Farxiga claims first SGLT2 kidney disease OK f...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks